|
TP53 mutations are associated with mutated MYD88 and CXCR4, and confer an adverse outcome in Waldenström macroglobulinaemia
|
|
Dual PAK4-NAMPT Inhibition Impacts Growth and Survival, and Increases Sensitivity to DNA-Damaging Agents in Waldenström Macroglobulinemia
|
|
Long survival in patients with Waldenström macroglobulinaemia diagnosed at a young age
|
|
Low risk of Pneumocystis jirovecii pneumonia and invasive aspergillosis in patients with Waldenström macroglobulinaemia on ibrutinib
|
|
Bruton tyrosine kinase degradation as a therapeutic strategy for cancer
|
|
Ibrutinib for the treatment of Bing-Neel syndrome: a multicenter study
|
|
Progression Risk Stratification of Asymptomatic Waldenström Macroglobulinemia
|
